EMERYVILLE, Calif., May 7, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management will be participating in the Oppenheimer 5th Annual Emerging Growth Conference, which will take place virtually on Tuesday, May 12, 2020. President and Chief Executive Officer John Melo, and Chief Financial Officer Han Kieftenbeld will host one-on-one meetings via teleconference throughout the day.
Amyris (Nasdaq: AMRS) is a science and technology leader in the research, development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets. Amyris uses an impressive array of exclusive technologies, including state-of-the-art machine learning, robotics and artificial intelligence. Our ingredients are included in over 3,000 products from the world's top brands, reaching more than 200 million consumers. Amyris is proud to own three consumer brands - all built around its No Compromise® promise of clean ingredients: Biossance™ clean beauty skincare, Pipette™ clean baby skincare and Purecane™, a zero-calorie sweetener naturally derived from sugarcane. For more information, please visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content to download multimedia:http://www.prnewswire.com/news-releases/amyris-to-participate-in-the-oppenheimer-5th-annual-emerging-growth-conference-on-may-12-301054571.html
SOURCE Amyris, Inc.